je.st
news
Teva, Active Biotech halt higher doses of oral MS drug in trials
2016-01-04 16:59:51| Biotech - Topix.net
Teva Pharmaceutical Industries and Active Biotech will discontinue higher doses of their oral drug in development for multiple sclerosis in two trials, citing the occurrence of non-fatal cardiovascular events in eight patients. Both trials of laquinimod will continue with the lower dose of 0.6 mg daily where there were no issues.
Tags: active
higher
drug
oral
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||
|
|||